• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

RevolutionEHR integrates with AMD iManager

Article

The integration will allow RevolutionEHR practices to simply and reduce data entry.

Madison, WI-RevolutionEHR announces that it is integrating AMD iManager to improve workflow and reduce duplicate data entry for offices utilizing both solutions. AMD iManager is a fully automated age-related macular degeneration (AMD) patient management suite that provides customers patient data extraction, identification and education to efficiently manage, monitor and treat patients at risk for AMD.

The software integration will enable RevolutionEHR practices to simplify the implementation process of incorporating AMD iManager into their practices, and reduce duplication of data entry between the two systems.

"One of the main goals of RevolutionEHR is to help our doctors help their patients,” says Scott Jens, OD, FAAO, chief executive officer of RevolutionEHR. “It's rare that a partnership allows us for such ease in achieving that goal and we are thrilled to work with the iManager team to assist our doctors with streamlined patient care .”

RevolutionEHR’s cloud-based architecture enables integrations with add-on solutions such as AMD iManager. The ability to connect additional offerings to RevolutionEHR through web services interfaces can improve office workflow.

 

Related Videos
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.